{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T11:20:05Z","timestamp":1696936805295},"reference-count":17,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2021,9,2]]},"DOI":"10.1080\/03007995.2021.1929893","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T17:53:06Z","timestamp":1621014786000},"page":"1461-1466","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Costs of minor bleeds in atrial fibrillation patients using a non-vitamin K antagonist oral anticoagulant"],"prefix":"10.1080","volume":"37","author":[{"given":"Darko","family":"Mitrovic","sequence":"first","affiliation":[{"name":"Department of Hospital Pharmacy, Tjongerschans, Heerenveen, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies","family":"Plomp","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Tjongerschans, Heerenveen, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Folkeringa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical Centre Leeuwarden, Leeuwarden, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nic","family":"Veeger","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Groningen University Medical Centre, Groningen, Netherlands"},{"name":"Department of Clinical Pharmacy, Medical Centre Leeuwarden, Leeuwarden, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talitha","family":"Feenstra","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, -Epidemiology and Economy, Faculty Pharmacy, University of Groningen, Groningen, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"van Roon","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Medical Centre Leeuwarden, Leeuwarden, Netherlands"},{"name":"Department of Pharmacotherapy, -Epidemiology and Economy, Faculty Pharmacy, University of Groningen, Groningen, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"issue":"11","key":"e_1_3_3_2_1","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: Communication from the SSC of the ISTH","volume":"13","author":"Kaatz S","year":"2015","unstructured":"Kaatz S, Ahmad D, Spyropoulos AC, the Subcommittee on Control of Anticoagulation, et\u00a0al. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: Communication from the SSC of the ISTH. J Thromb Haemost. 2015;13(11):2119\u20132126.","journal-title":"J Thromb Haemost"},{"key":"e_1_3_3_3_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2019.07.026","article-title":"Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding","volume":"182","author":"Xu Y","year":"2019","unstructured":"Xu Y, Schulman S, Dowlatshahi D, et\u00a0al. Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding. Thromb Res. 2019;182(July):12\u201319.","journal-title":"Thromb Res"},{"issue":"8","key":"e_1_3_3_4_1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/13696998.2019.1603156","article-title":"Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants","volume":"22","author":"Rozjabek HM","year":"2019","unstructured":"Rozjabek HM, Coleman CI, Ashton V, et\u00a0al. Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants. J Med Econ. 2019;22(8):751\u2013759.","journal-title":"J Med Econ"},{"issue":"8","key":"e_1_3_3_5_1","doi-asserted-by":"crossref","first-page":"e103974","DOI":"10.1371\/journal.pone.0103974","article-title":"Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands","volume":"9","author":"Stevanovi\u0107 J","year":"2014","unstructured":"Stevanovi\u0107 J, Pompen M, Le HH, et\u00a0al. Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands. PLoS One. 2014;9(8):e103974.","journal-title":"PLoS One"},{"issue":"9","key":"e_1_3_3_6_1","doi-asserted-by":"crossref","first-page":"e0222658","DOI":"10.1371\/journal.pone.0222658","article-title":"Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings","volume":"14","author":"de Jong LA","year":"2019","unstructured":"de Jong LA, Groeneveld J, Stevanovic J, et\u00a0al. Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings. PLOS One. 2019;14(9):e0222658\u201317.","journal-title":"PLOS One"},{"issue":"4","key":"e_1_3_3_7_1","first-page":"387","article-title":"Clinically relevant non-major bleeding with oral anticoagulants: Non-major may not be trivial","volume":"16","author":"Franco L","year":"2018","unstructured":"Franco L, Becattini C, Vanni S, et\u00a0al. Clinically relevant non-major bleeding with oral anticoagulants: Non-major may not be trivial. Blood Transfus. 2018;16(4):387\u2013391.","journal-title":"Blood Transfus"},{"issue":"6","key":"e_1_3_3_8_1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood-2014-03-563577","article-title":"Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry","volume":"124","author":"Beyer-Westendorf J","year":"2014","unstructured":"Beyer-Westendorf J, F\u00f6rster K, Pannach S, et\u00a0al. Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry. Blood. 2014;124(6):955\u2013962.","journal-title":"Blood"},{"key":"e_1_3_3_9_1","unstructured":"van Ommen CH Piersma-Wichers G van Diermen DE et al. Landelijke Standard Keten Antistolling 2.0 voor de eerste- en tweedelijns zorg. Kennis instituut van Medisch Specialisten 2014. https:\/\/www.nhg.org\/sites\/default\/files\/content\/nhg_org\/uploads\/lska.pdf."},{"key":"e_1_3_3_10_1","first-page":"1","article-title":"Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg","author":"Hakkaart-van Roijen L","year":"2016","unstructured":"Hakkaart-van Roijen L, van der Linden N, Bouwmans C, et\u00a0al. Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg. Zorginstituut Ned. 2016;1:1\u201373.","journal-title":"Zorginstituut Ned"},{"issue":"1","key":"e_1_3_3_11_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1478-7547-8-21","article-title":"Lifetime health effects and medical costs of integrated stroke services - a non-randomized controlled cluster-trial based life table approach","volume":"8","author":"Baeten SA","year":"2010","unstructured":"Baeten SA, van Exel NJA, Dirks M, et\u00a0al. Lifetime health effects and medical costs of integrated stroke services - a non-randomized controlled cluster-trial based life table approach. Cost Eff Resour Alloc. 2010;8(1):21.","journal-title":"Cost Eff Resour Alloc"},{"key":"e_1_3_3_12_1","unstructured":"Central Bureau voor Statistiek (CBS). StatLine - Jaarmutatie HICP; Nederland eurozone en Europese Unie 2015\u2009=\u2009100 [Internet] [cited 2020 Jan 31]. Available from: https:\/\/opendata.cbs.nl\/statline\/#\/CBS\/nl\/dataset\/83135NED\/table?ts=1580124435578."},{"key":"e_1_3_3_13_1","unstructured":"Stichting Farmaceutische Kerngetallen. Pharmaceutisch Weekblad. Jaargang 154 Nr 37. Available from: https:\/\/www.sfk.nl\/publicaties\/PW\/2019\/anticoagulantia-doac-blijft-terrein-winnen-op-vka."},{"issue":"11","key":"e_1_3_3_14_1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Hylek EM","year":"2011","unstructured":"Hylek EM, Hanna M, Al-Khalidi HR, et\u00a0al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981\u2013992.","journal-title":"N Engl J Med"},{"key":"e_1_3_3_15_1","first-page":"225","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","author":"Pisano E","year":"2005","unstructured":"Pisano E, Gatsonis C, Boineau R, et\u00a0al. Dabigatran versus warfarin in patients with atrial fibrillation. Heart Fail. 2005;361:225\u2013237.","journal-title":"Heart Fail"},{"issue":"1","key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12913-017-2331-z","article-title":"S. Costs of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation \u2013 a nationwide cohort study","volume":"17","author":"Jakobsen M","year":"2017","unstructured":"Jakobsen M, Kolodziejczyk C, Klausen FE, et\u00a0al. S. Costs of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation \u2013 a nationwide cohort study. BMC Health Serv. Res. 2017;17(1):398.","journal-title":"BMC Health Serv. Res"},{"issue":"5","key":"e_1_3_3_17_1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2217\/fca-2019-0033","article-title":"Costs of gastrointestinal bleeding events in atrial fibrillation: a UK clinical practice research datalink study","volume":"15","author":"Ramagopalan SV","year":"2019","unstructured":"Ramagopalan SV, Samnaliev M, Weir S, et\u00a0al. Costs of gastrointestinal bleeding events in atrial fibrillation: a UK clinical practice research datalink study. Future Cardiol. 2019;15(5):367\u2013375.","journal-title":"Future Cardiol"},{"issue":"4","key":"e_1_3_3_18_1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s11552-014-9618-x","article-title":"Differences in response rates between mail, e-mail, and telephone follow-up in hand surgery research","volume":"9","author":"Nota SPFT","year":"2014","unstructured":"Nota SPFT, Strooker JA, Ring D. Differences in response rates between mail, e-mail, and telephone follow-up in hand surgery research. Hand. 2014;9(4):504\u2013510.","journal-title":"Hand"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2021.1929893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T13:05:56Z","timestamp":1696856756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2021.1929893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,2]]}},"alternative-id":["10.1080\/03007995.2021.1929893"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2021.1929893","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-12-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}